Cortico-spinal coupling along descending pain system differentiates between opioid and saline treatment in healthy participants
Data files
Apr 07, 2026 version files 57.40 MB
-
Figure1_sourcedata1_painratings-baseline.mat
687 B
-
Figure1_sourcedata2_painratings-treatment.mat
702 B
-
Figure2A_sourcedata.nii
8.49 MB
-
Figure2B_sourcedata.nii
8.49 MB
-
Figure3_sourcedata.nii
6.44 MB
-
Figure4_sourcedata.nii
8.49 MB
-
Figure5_sourcedata.nii
8.49 MB
-
Figure6_sourcedata1_NPSscores-baseline.mat
1.06 KB
-
Figure6_sourcedata2_NPSscores-treatment.mat
1.07 KB
-
Figure7B_sourcedata.nii
8.49 MB
-
Figure7C_sourcedata.nii
8.49 MB
-
README.md
3.54 KB
Abstract
Opioids are potent analgesic drugs with widespread cortical, subcortical and spinal targets. In particular, the central pain system comprising ascending and descending pain pathways has high opioid receptor densities and is thus crucial for opioid analgesia. Here, we investigated effects of the opioid remifentanil in a large sample (n=78) of healthy male participants using combined cortico-spinal fMRI. This approach offers the possibility to measure BOLD responses simultaneously in the brain and spinal cord allowing us to investigate the role of cortico-spinal coupling in opioid analgesia. Our data show that opioids altered activity in regions involved in pain processing such as somatosensory regions including the spinal cord and pain modulation such as prefrontal regions. Moreover, coupling strength along the descending pain system, i.e. between the medial prefrontal cortex, periaqueductal gray and spinal cord was stronger in participants who reported stronger analgesia during opioid treatment while the reversed pattern was observed in the control group. These results indicate that coupling along the descending pain pathway is a potential mechanism of opioid analgesia and can differentiate between opioid analgesia and unspecific reductions in pain such as habituation.
Dataset DOI: 10.5061/dryad.bvq83bk9k
Description of the data and file structure
The dataset includes supplementary information for all figures provided in the publication. The study compared BOLD responses in the brain and spinal cord between participants that either received saline or the opioid agonist remifentanil (N = 78). Individual pain ratings, NPS scores and fMRI contrast images are provided to support all reported results in the publication.
Files and variables
File: Figure1_sourcedata1_painratings-baseline.mat
Description: Baseline pain ratings (0-100) for all participants
Variables
- subID, group, pain rating
File: Figure1_sourcedata2_painratings-treatment.mat
Description: Treatment pain ratings (0-100) for all participants
Variables
- subID, group, pain rating
File: Figure2B_sourcedata.nii
Description: Contrast image depicting regions that show increased BOLD during remifentanil treatment compared to saline
File: Figure2A_sourcedata.nii
Description: Contrast image depicting regions that show reduced BOLD during remifentanil treatment compared to saline
File: Figure3_sourcedata.nii
Description: Spinal contrast image depicting regions that show reduced BOLD during remifentanil treatment compared to saline
File: Figure6_sourcedata1_NPSscores-baseline.mat
Description: Baseline NPS scores for every participant
Variables
- subID, group, NPS score
File: Figure6_sourcedata2_NPSscores-treatment.mat
Description: Treatment NPS scores for every participant
Variables
- subID, group, NPS score
File: Figure4_sourcedata.nii
Description: Brain regions showing a negative inter-subject correlation between BOLD reduction and reported analgesia during the treatment phase
File: Figure7B_sourcedata.nii
Description: Correlation between reported analgesia during the treatment phase and coupling strength between the prefrontal cortex and PAG
File: Figure7C_sourcedata.nii
Description: Correlation between reported analgesia during the treatment phase and coupling strength between the spinal cord and PAG
File: Figure5_sourcedata.nii
Description: Brain regions showing a positive inter-subject correlation between BOLD reduction and reported analgesia during the treatment phase
Usage Notes
.mat: matlab files containing numerical values such as pain ratings and NPS scores per participant for baseline and treatment conditions. Columns represent the subject ID, group ID (1 = NaCl, 2 = Remi50, 3 = Remi100) and the rating/NPS score, respectively. Mat files can be opened with Octave using the command load('filename'). The command results(:,3) would output the respective pain ratings/NPS scores.
.nii: nifti images containing second-level contrast images for the respective figure which can be opened with any fMRI visualization software such as Mango or MRIcroGL.
Human subjects data
The dataset only contains non-identifiable data as all contrast images represent group statistics in MRI template space that do not represent data of individual participants. Individual pain ratings and NPS scores were anonymized by assigning participants a random number.
All participants consented to sharing their data in an anonymized format.
mat files: Subject, Group (1 = NaCl, 2 = Remi50, 3 = Remi100), Rating/NPS score
nii files: Second-level contrast images for respective figures
